Dong-E-E-Jiao Co.,Ltd.: history, ownership, mission, how it works & makes money

From its origins as the Shandong Dong-E-E-Jiao Factory in 1952 to its public listing as 000423.SZ in 1996 and integration into China Resources Group, Dong-E-E-Jiao has grown into a vertically integrated tonic powerhouse-boasting RMB 13.087 billion in total assets at the end of 2024 and a workforce of 4,095 employees (up 11.34% year-on-year)-while controlling roughly 75% of China's donkey-hide gelatin production and 90% of exports; with 642.46 million shares outstanding, about 30.01% held by institutions, a market capitalization of RMB 31.28 billion and an enterprise value of RMB 23.21 billion (as of December 18, 2025), the company leverages 3,000 years of TCM heritage, modern R&D centers, and a dominant brand (ranked 16th on the China 500 with a brand value of RMB 49.7 billion in 2025) to sell Ejiao, patent medicines and health foods domestically and abroad-read on to see how its ownership, mission, operations and revenue streams knit together to sustain this market-leading position

Dong-E-E-Jiao Co.,Ltd. (000423.SZ): Intro

Dong-E-E-Jiao Co.,Ltd. (000423.SZ) is the leading Chinese producer of donkey-hide gelatin (Ejiao), a traditional Chinese medicine ingredient and high-value nourishing product. Founded in 1952 in Dong'e County, Shandong, the company has evolved from a municipal factory to a listed enterprise and a key subsidiary within a central state-owned enterprise group.

• Founded: 1952 as Shandong Dong-E-E-Jiao Factory
• Joint-stock conversion: 1993
• Listed on Shenzhen Stock Exchange: 1996
• Became China Resources Group subsidiary: 2005

More on the company's comprehensive profile and business model: Dong-E-E-Jiao Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

History & Milestones

• 1952 - Established to produce Ejiao in Dong'e, Shandong, leveraging local traditional know-how.
• 1993 - Reorganized into a joint-stock limited company to modernize governance and attract investment.
• 1996 - Went public on the Shenzhen Stock Exchange (ticker: 000423.SZ), accessing capital markets for expansion.
• 2005 - Integrated into China Resources Group as a subsidiary, gaining scale, distribution strength, and state-backed resources.
• 2024 - Continued operational expansion with tangible growth in scale and workforce.

Recent Scale & Financial Position (selected 2024 metrics)

Ownership & Corporate Structure

• Majority/controlling shareholder: China Resources Group (central state-owned enterprise) following integration in 2005.
• Public float: Shares traded on Shenzhen Stock Exchange under 000423.SZ provide market liquidity and external investors exposure.
• Corporate governance: Joint-stock structure since 1993 with board oversight appropriate for a listed company and state-owned parent involvement.

Mission & Strategic Positioning

• Mission: To preserve and scale the production of Ejiao while modernizing quality control, R&D, and branded consumer channels.
• Positioning: Market leader in traditional medicinal gelatin with strong brand heritage, integrated supply chain, and growing consumer health product portfolio.

How It Works - Operations & Value Chain

• Raw material procurement: Secures donkey hide input and other traditional raw materials through contracted suppliers and vertically integrated sourcing where feasible.
• Manufacturing: Processes hides into Ejiao using proprietary/standardized extraction and concentration processes, quality testing, and packaging for pharmaceuticals, health supplements, and gift retail segments.
• R&D & quality: Invests in quality control, product development (formulations, ready-to-consume products) and compliance with national TCM and food safety standards.
• Distribution: Multi-channel distribution including pharmacy networks, specialty TCM stores, e-commerce platforms, and large-scale retail partners-benefiting from China Resources' broader distribution reach.

How It Makes Money - Revenue Streams

• Core product sales: Direct sales of Ejiao blocks, powders, and capsule/ready-to-drink formulations to wholesale, retail, and institutional buyers.
• Branded consumer products: Higher-margin packaged health supplements and gift products aimed at consumer markets (seasonal and festival demand).
• Pharmaceutical/ingredient sales: Supplying Ejiao as an ingredient to TCM manufacturers and downstream formulators.
• Licensing and partnerships: Strategic collaborations, co-branded products, and distribution agreements leveraging the China Resources ecosystem.

Dong-E-E-Jiao Co.,Ltd. (000423.SZ): History

• Parent company: China Resources Pharmaceutical Group Ltd., under state-owned China Resources Group.
• Exchange listing: Shenzhen Stock Exchange, ticker 000423.SZ.
• Shares outstanding: 642.46 million (as of December 18, 2025).
• Institutional ownership: ~30.01% of shares.
• Other holders: individual investors and company insiders making up the remaining free float.
• Market capitalization: RMB 31.28 billion (as of December 18, 2025).
• Enterprise value: RMB 23.21 billion (as of December 18, 2025).

• Product portfolio: core ejiao products (block, powder, ready-to-drink formulations), health supplements, and TCM-derived consumer goods sold via retail, e-commerce, and medical channels.
• Vertical integration: controls procurement of raw donkey hide, processing, quality control and branded distribution - improving margins and supply reliability.
• Revenue model: product sales (retail & institutional), licensing and co-branding, plus seasonal and gift-driven peak sales for premium ejiao items.
• Profit drivers: strong brand recognition, high gross margins on value-added formulations, and scalable online distribution reducing channel costs.

Dong-E-E-Jiao Co.,Ltd. (000423.SZ): Ownership Structure

• Mission: Promote a healthy, beneficial society through safe, effective tonic products that combine ~3,000 years of TCM heritage with modern nutritional and manufacturing science.
• Values: Integrity, dedication, customer-first focus, cultural preservation, technological innovation, and rigorous full-industry-chain quality control.
• Strategic aim: Be the most trusted leader in public tonic health products and set industry benchmarks in quality and consumer experience.

• Product portfolio: E-jiao (donkey-hide gelatin) core tonics, ready-to-drink health beverages, capsules, and seasonal/limited-product lines leveraging brand heritage and R&D formulations.
• Revenue model: Direct retail (branded stores, e-commerce), wholesale to pharmacies and distributors, institutional/healthcare channels, and licensing/derivative products.
• Quality & tech: Owns integrated supply chain from raw-material procurement (collagen/glycerin/herbal inputs) through extraction, GMP-standard production, and traceable packaging.

• Brand premium: Long-standing cultural recognition enables pricing power and high-margin heritage product lines.
• Channel mix: Growing e-commerce and health-channel sales complement brick-and-mortar network to stabilize seasonal demand.
• R&D & product extension: Investment in nutritional science and new forms (liquids, sachets, supplements) to broaden addressable market.
• Supply-chain control: Vertical integration of key inputs and GMP-certified production reduce quality risk and support traceability, which is core to consumer trust.

Dong-E-E-Jiao Co.,Ltd. (000423.SZ): Mission and Values

• Core products: donkey-hide gelatin (E-Jiao) primary formulations, compounded TCM preparations, health supplements and consumer-facing packaged goods.
• Vertical integration: raw-hide sourcing, processing, gelatin extraction, formulation, packaging and retail/distribution under unified quality standards.
• R&D and standards: integration of modern analytical methods with traditional recipes via an established national TCM engineering technology research center and a postdoctoral research workstation.
• Brand & market position: China Well-known Trademark with leading domestic market share in the E-Jiao category and growing exports to Southeast Asia, Europe and the Americas.

• Sourcing: Long-term supply agreements and vertical control over donkey-hide sources to secure raw-material quality and traceability.
• Manufacturing: GMP-compliant plants using both traditional extraction and modern process controls to ensure batch consistency and safety testing (heavy metals, pesticides, microbial limits).
• R&D: In-house research teams supported by the national TCM engineering technology research center and postdoctoral workstation drive formulation optimization, new dosage forms, and clinical/quality studies.
• Distribution: Omni-channel marketing-hospital and clinic channels, pharmacy chains, company-owned retail, e-commerce platforms and international distributors.

• Traceability systems track raw hides from suppliers through processing to finished batches, reducing contamination and protecting brand integrity.
• Integrated quality teams conduct routine chemical, microbiological and heavy-metal testing; manufacturing meets national GMP and industry-specific standards.
• Scientific validation: clinical research collaborations and analytical method development at the company's research center improve product profiles and support new registrations.

• Product sales: Core revenues from packaged E-Jiao formulations sold via hospitals, pharmacies, retail outlets and e-commerce. Premium and heritage SKUs command higher gross margins.
• Export & licensing: Sales to international distributors and selective licensing of formulations for foreign markets extend revenue beyond domestic channels.
• Value-added services: Branded seasonal products, gift-pack SKUs and derivative health supplements increase per-customer spend and improve margin mix.
• Scale & cost control: Vertical integration reduces procurement variability and supports stable gross margins despite raw-material pressure.

• Advantages: Strong brand equity, category leadership, integrated supply chain, institutionalized R&D and established export channels.
• Risks: Raw-material supply pressure (donkey-hide availability), regulatory shifts in TCM export/import rules, and competition from substitutes or synthetic alternatives.

Dong-E-E-Jiao Co.,Ltd. (000423.SZ): How It Works

Dong-E-E-Jiao Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

Dong-E-E-Jiao (000423.SZ) operates as the leading producer and seller of donkey-hide gelatin (Ejiao) and related traditional Chinese medicine (TCM) products. Its business model combines raw-material procurement, vertically integrated manufacturing, branded retail and wholesale distribution, R&D and exports. The company monetizes brand equity, proprietary formulations and a broad product range to serve both traditional TCM consumers and modern health-food markets.

• Core revenue source: sale of Ejiao (donkey-hide gelatin) in concentrated, slice and ready-to-drink formats, plus cross-category derivatives (capsules, syrups, candies).
• Secondary sources: traditional Chinese patent medicines, health foods, conventional snacks and seasonal gift-box products.
• Distribution channels: owned retail stores, e-commerce platforms, pharmacy chains, institutional sales (hospitals/clinics) and export markets.

Key operational elements that enable revenue generation:

• Vertical integration-from contracted donkey skin procurement and breeding partnerships to in-house gelatin extraction and product formulation-reduces input volatility and secures supply.
• Strong brand positioning and premium pricing supported by heritage storytelling, quality certification and marketing across digital and offline channels.
• Product diversification: expanding into health foods and more mainstream FMCG items to broaden TAM and smooth seasonal demand swings.
• Export focus: targeted international markets where TCM and health supplements have elevated demand, supporting foreign-currency revenue and growth.

Revenue composition (approximate):

• Ejiao products: 60-70% of revenue - flagship capsules, concentrated gelatin, ready-to-drink and gift-box lines.
• TCM patent medicines: 15-20% - multi-ingredient formulas leveraging the brand's trust.
• Health foods and FMCG: 10-15% - snacks, beverages and nutritional supplements designed to expand consumer reach.
• Exports: 12-15% - concentrated in East Asia, Southeast Asia, and diaspora markets in Europe and North America.

How value is captured at each stage:

• Raw material control - long-term procurement agreements and vertical partnerships stabilize input costs and ensure quality.
• Proprietary processing - specialized gelatin extraction and concentration create differentiated product forms with higher margins.
• Brand premium - Dong-E-E-Jiao commands higher price points relative to generic gelatin or lesser-known TCM brands.
• Channel mix optimization - direct retail and e-commerce enable higher gross margins; pharmacy and institutional channels provide volume.
• Seasonality management - gift-box products and seasonal marketing (e.g., Lunar New Year) drive concentrated sales spikes and higher ASPs.

Unit economics and pricing dynamics:

• Average selling price (Ejiao concentrate): varies by SKU, typically RMB 300-1,200 per unit for premium retail SKUs.
• Cost drivers: donkey-skin procurement (largest variable), energy and labor for extraction, packaging for gift/retail presentation.
• Margin drivers: higher-margin SKUs include ready-to-drink and capsules; export orders often carry premium margins after logistics.

Strategic levers for future revenue growth:

• Product innovation - expanding functional foods and nutraceutical offerings to capture younger consumers.
• International expansion - deeper penetration in Asia-Pacific and targeted Western markets via partnerships and compliance certification.
• Supply-chain resilience - investments in domestically controlled sources and breeding programs to reduce price volatility.
• Digital sales - scaling e-commerce and CRM-driven repeat purchase programs to increase lifetime value.

Dong-E-E-Jiao Co.,Ltd. (000423.SZ): How It Makes Money

• Core product sales: donkey-hide gelatin (ejiao) in powder, block and ready-to-consume formats sold under flagship brands (large domestic retail, e-commerce, and institutional channels).
• Branded health & beauty lines: "Taohuajie" (nourishing energy & beauty) and the expanding male-focused "Royal Weichang 1619" matrix.
• Herbal & tonic categories: "Zhuangben" cistanche deserticola series and other TCM formulations developed via in-house R&D.
• Exports and international distribution: bulk and finished-product exports to Asian and global markets, driven by high export share in the category.
• Ancillary revenues: licensing, co-branding, and value-added services (e.g., health consults, experiential retail).

• Competitive moat: near-monopolistic supply control of raw ejiao and recognized national brand equity, enabling pricing power and high export penetration.
• Innovation & pipeline: ongoing product diversification (men's tonic matrix, cistanche category) and quality-focused upgrades to capture premium market segments.
• Future growth drivers: brand-strength-based premiumization, expanded export channels, and new OTC/nutraceutical SKUs targeting younger consumers.